Is My Fibroadenoma Biopsy Radiologic-Pathologic Concordant?
At a Glance
After a breast fibroadenoma biopsy, doctors compare the imaging with the pathology to confirm the sample explains the abnormality. If the results do not match, repeat biopsy or surgical removal may be needed rather than simple monitoring.
When you receive a benign (non-cancerous) biopsy result like a fibroadenoma, you might feel relief, confusion, or even continued worry. To help you feel confident in your results, your medical team performs an important review step called radiologic-pathologic concordance.
In simple terms, this means that the biopsy result makes sense and adequately explains the original abnormality seen on your ultrasound, mammogram, or MRI [1][2]. It is not enough for the tissue sample to simply be benign; it must be the right benign tissue [3]. Typically, the breast radiologist makes this determination by reviewing your imaging alongside the pathologist’s report, and they may consult with your treating clinician [1].
How Your Team Determines Concordance
To determine if your results are concordant, your radiologist asks several key questions:
- Does the diagnosis fit the picture? A fibroadenoma typically looks like a smooth, oval mass on an ultrasound. If your imaging showed an irregular or spiculated (spiky-looking) mass, a simple fibroadenoma diagnosis might not fit the picture [1][4].
- Was the intended target sampled? The radiologist reviews post-biopsy imaging to see the location of the tiny metallic marker placed during the procedure. While the clip does not always sit exactly in the center due to tissue shifting, its location helps confirm that the needle sampled the correct area [2][5].
- Were enough representative samples obtained? They ensure the pathologist received enough tissue cores to make a reliable diagnosis [2].
For complex cases, this assessment might happen during a multidisciplinary review—a meeting where doctors from different specialties discuss your case together—but many routine cases are correlated directly by the radiologist [6][7].
Concordant Benign Results: When Monitoring is Safe
A concordant benign result means the imaging and pathology are considered consistent. For example, if your ultrasound showed a classic oval-shaped lump and the pathologist confirmed it is an uncomplicated fibroadenoma, the results match [8][9].
When your team confirms radiologic-pathologic concordance and there are no other concerning features (such as a very large size, rapid growth, or atypical cells), surveillance or monitoring is a standard next step [8][9]. Your exact follow-up plan will depend on your age, the imaging category (often called a BI-RADS score), and local protocols [10]. Routine surgical removal is usually not required for a concordant fibroadenoma, though your doctor might recommend it if the mass grows significantly or for other personal clinical reasons [10][11].
Discordant Benign Results: When More Testing is Needed
A discordant benign result (or radiologic-pathologic discordance) means the tissue sample is benign, but it does not explain the suspicious features seen on your imaging [1][12]. For instance, if your imaging showed a highly suspicious area but the biopsy only pulled out normal breast tissue or an incidental fibroadenoma that happened to be sitting nearby, the results do not match [13][14].
A discordant result cannot simply be monitored, because there is a risk that the needle undersampled the area (didn’t get enough of the right tissue) or missed a nearby malignancy (cancer) [1][4]. If your results are discordant, your care team will recommend prompt diagnostic resolution—meaning taking specific steps to get a definitive answer [6][15]. Depending on the lesion’s location, size, and how it was originally biopsied, this may involve:
- Repeat Image-Guided Biopsy: Performing another core needle biopsy to try and sample the correct area [4].
- Vacuum-Assisted Biopsy (VAB): A procedure that uses a slightly larger needle and a gentle vacuum to remove more tissue. This is often an effective next step, but may not be available or appropriate for every lump [15][16].
- Surgical Excision: An operation to remove the entire area of concern. Unlike a needle biopsy, this involves local anesthesia with sedation or general anesthesia, recovery time, and a scar, but it provides the most complete tissue sample for the pathologist [1][11].
Clear communication is essential. If your doctor recommends another biopsy or surgery after a benign result, it is not necessarily because they found cancer. It is because the first sample didn’t provide a reliable answer for what was seen on the imaging, and they want to be certain of your diagnosis [6][17].
What to Look For in Your Report
When reading your medical reports, look for:
- The BI-RADS Category: A numbering system (usually 1 through 6) that describes the level of suspicion on your imaging.
- The Pathology Diagnosis: What the tissue actually was (e.g., fibroadenoma).
- The Concordance Statement: An explicit note from the radiologist stating whether the pathology results are “concordant” or “discordant” with the imaging.
Common questions in this guide
What does radiologic-pathologic concordance mean after a fibroadenoma biopsy?
Can a benign breast biopsy still require more testing?
How do doctors know the biopsy sampled the correct breast lump?
Do I need surgery if my biopsy shows a fibroadenoma?
What should I look for in my breast biopsy and imaging reports?
Related questions
Show more
Get notified when new evidence is published on breast fibroadenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.
Yincharoen P, Sharma CP, Tawanwongsri W
Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.
PMID: 42201021 - 2
Demystifying Breast Disease Markers.
Wells VA, Medeiros I, Shevtsov A, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(10)):e220151 doi:10.1148/rg.220151.
PMID: 37676826 - 3
Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.
Park VY, Kim EK, Moon HJ, et al.
Ultrasonography (Seoul, Korea) 2018; (37(2)):107-120 doi:10.14366/usg.17049.
PMID: 29169231 - 4
Radiologic-Pathologic Discordance and Outcome After MRI-Guided Vacuum-Assisted Biopsy.
Lewin AA, Heller SL, Jaglan S, et al.
AJR. American journal of roentgenology 2017; (208(1)):W17-W22 doi:10.2214/AJR.16.16404.
PMID: 27786559 - 5
Troubleshooting to Overcome Technical Challenges in Image-guided Breast Biopsy.
Chesebro AL, Chikarmane SA, Ritner JA, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(3)):705-718 doi:10.1148/rg.2017160117.
PMID: 28410063 - 6
Impact of multidisciplinary radiologic-pathologic correlation conference for benign image-guided breast biopsies on discordance rates and patient outcomes in a community teaching hospital.
Olayinka O, Kaur G, Agarwal R, et al.
Annals of diagnostic pathology 2022; (57()):151864 doi:10.1016/j.anndiagpath.2021.151864.
PMID: 34972038 - 7
Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.
Prakash S, Venkataraman S, Slanetz PJ, et al.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):122-9.
PMID: 26632099 - 8
Is excision biopsy of fibroadenomas based solely on size criteria warranted?
Neville G, Neill CO, Murphy R, et al.
The breast journal 2018; (24(6)):981-985 doi:10.1111/tbj.13069.
PMID: 29802656 - 9
Trends, Outcomes, and Costs of Surgical Excisional Biopsy for Fibroadenoma of the Breast.
Rath P, Vasigh M, Soleimani T, Euhus DM
World journal of surgery 2025; (49(4)):797-803 doi:10.1002/wjs.12542.
PMID: 40059293 - 10
Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?
Daroles J, Borget I, Suciu V, et al.
European journal of cancer (Oxford, England : 1990) 2017; (85()):23-30 doi:10.1016/j.ejca.2017.08.002.
PMID: 28881248 - 11
Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Lee A, James J, Whisker L, et al.
Annals of the Royal College of Surgeons of England 2022; (104(5)):361-366 doi:10.1308/rcsann.2021.0208.
PMID: 34939848 - 12
Discrepancies between radiological and histological findings in preoperative core needle (CNB) and vacuum-assisted (VAB) breast biopsies.
Jörg I, Wieler J, Elfgen C, et al.
Journal of cancer research and clinical oncology 2021; (147(3)):749-754 doi:10.1007/s00432-020-03481-7.
PMID: 33284380 - 13
Pseudoangiomatous Stromal Hyperplasia: Radiologic-Pathologic Correlation.
Speer ME, Yoon EC, Berg WA, Chang Sen LQ
Journal of breast imaging 2023; (5(1)):67-72 doi:10.1093/jbi/wbac051.
PMID: 36778653 - 14
Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management.
Guirguis MS, Adrada B, Santiago L, et al.
Insights into imaging 2021; (12(1)):53 doi:10.1186/s13244-021-00991-x.
PMID: 33877461 - 15
Role of ultrasound-guided vacuum-assisted breast biopsy in the management of radiologic-pathologic discordance: a retrospective single-centre study.
Vatteroni G, Pinna G, Trimboli RM, et al.
La Radiologia medica 2024; (129(10)):1454-1462 doi:10.1007/s11547-024-01864-1.
PMID: 39102107 - 16
Image-guided biopsy of breast lesions-when to use what biopsy technique.
Sanderink WBG, Camps-Herrero J, Athanasiou A, et al.
Insights into imaging 2025; (16(1)):208 doi:10.1186/s13244-025-02084-5.
PMID: 40996584 - 17
Radiology-Pathology Concordance Conference: Utility and Success in Clinical Practice.
Robinson KA, Maimone S, Sonam S, et al.
Journal of breast imaging 2026; (8(2)):190-203 doi:10.1093/jbi/wbaf053.
PMID: 41671050
This page is for informational purposes only and does not constitute medical advice. Your breast radiologist and treating clinician should interpret your results and recommend follow-up.